|

CD117 CAR T-cells Clinical Trials

1 actively recruiting trial

Also known as: CD117 CAR T-cells injection

Pipeline

Early 1: 1

Top Sponsors

  • Zhejiang University1

Indications

  • Acute Myeloid Leukemia1
  • Cancer1

Other1 trial

Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.